Lyme neuroborreliosis in children: Report of nine cases and a review of the literature.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 03 04 2018
revised: 07 01 2019
accepted: 09 02 2019
pubmed: 20 3 2019
medline: 21 8 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

Lyme neuroborreliosis is a bacterial infection caused by the dissemination and proliferation of a Borrelia species in the central nervous system. Neuroborreliosis occurs after transmission of the pathogen from an infected tick to a human host during a tick bite. We report nine cases of pediatric neuroborreliosis collected by the National Observatory of Pediatric Bacterial Meningitis in France between 2001 and 2012. The nine children, aged 4-13 years, were identified in northern and eastern France and had the following clinical features: meningeal irritation alone or with facial palsy, or isolated facial palsy. All cases showed anti-Borrelia antibodies in cerebrospinal fluid or serum, or with a positive Borrelia PCR in the CSF. The outcome was favorable in all cases after a 2- to 3-week course of third-generation cephalosporin. On the basis of these nine pediatric cases, this study provides an update on the epidemiology, pathophysiology, diagnostic strategy, and treatment of neuroborreliosis, with insight into the specific features of pediatric neuroborreliosis and the difficulties encountered in the diagnosis of this infection.

Identifiants

pubmed: 30885602
pii: S0929-693X(19)30034-X
doi: 10.1016/j.arcped.2019.02.010
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antibodies, Bacterial 0
DNA, Bacterial 0
Ceftriaxone 75J73V1629
Amoxicillin 804826J2HU
Cefotaxime N2GI8B1GK7

Types de publication

Case Reports Journal Article Review

Langues

eng

Pagination

133-137

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

H Guet-Revillet (H)

Service de microbiologie, hôpital Necker-enfants-malades, Assistance publique-hôpitaux de Paris, 149, rue de Sèvres, 75015 Paris, France. Electronic address: guet-revillet.h@chu-toulouse.fr.

C Levy (C)

Groupe de pathologie infectieuse pédiatrique (GPIP), CHU de Lenval, hôpitaux pédiatriques, 57, avenue de la Californie, 06200 Nice, France; Association clinique et thérapeutique infantile du Val-de-Marne (ACTIV), 27, rue d'Inkermann, 94100 Saint-Maur-des-Fossés, France; Centre de recherche clinique, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France; UMR 955, GRC, groupe d'étude des maladies infectieuses néonatales et infantiles (GEMINI), université Paris Est, IMRB Institut Mondor de recherche biomédicale, 94000 Créteil, France.

C Vallet (C)

Service de pédiatrie, centre hospitalier Compiègne-Noyon, 8, avenue Henri-Adnot, ZAC de Mercières 3, 60200 Compiègne, France.

V Maghraoui-Slim (V)

Unité policlinique pédiatrique, hôpital Bicêtre, 8, rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France.

M-A Dommergues (MA)

Groupe de pathologie infectieuse pédiatrique (GPIP), CHU de Lenval, hôpitaux pédiatriques, 57, avenue de la Californie, 06200 Nice, France; Service de pédiatrie, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France.

V Hentgen (V)

Service de pédiatrie, centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France.

C Paget (C)

Service de pédiatrie, centre hospitalier de Chambéry, place Lucien-Biset, 73011 Chambéry, France.

V Laugel (V)

Service de pédiatrie 1, hôpital de Hautepierre, 1, avenue Molière, 67200 Strasbourg, France.

R Cohen (R)

Groupe de pathologie infectieuse pédiatrique (GPIP), CHU de Lenval, hôpitaux pédiatriques, 57, avenue de la Californie, 06200 Nice, France; Association clinique et thérapeutique infantile du Val-de-Marne (ACTIV), 27, rue d'Inkermann, 94100 Saint-Maur-des-Fossés, France; Centre de recherche clinique, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France; UMR 955, GRC, groupe d'étude des maladies infectieuses néonatales et infantiles (GEMINI), université Paris Est, IMRB Institut Mondor de recherche biomédicale, 94000 Créteil, France.

A Ferroni (A)

Service de microbiologie, hôpital Necker-enfants-malades, Assistance publique-hôpitaux de Paris, 149, rue de Sèvres, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH